bibliographic resource 8212790 [br/8212790]
https://w3id.org/oc/corpus/br/8212790

is a
title
  • A phase I/II study of dovitinib (TKI258), a FGFR and VEGFR inhibitor, in patients (pts) with advanced or metastatic renal cell cancer: Phase I results.
publication date
  • 2010-01-01
contributor
format
identifier
part of